EP Wealth Advisors LLC Takes Position in Revvity Inc. $RVTY

EP Wealth Advisors LLC acquired a new stake in Revvity Inc. (NYSE:RVTY) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 4,569 shares of the company’s stock, valued at approximately $508,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in RVTY. Ascentis Independent Advisors purchased a new position in shares of Revvity during the first quarter worth $29,000. CYBER HORNET ETFs LLC purchased a new stake in Revvity in the second quarter valued at $32,000. MUFG Securities EMEA plc purchased a new stake in Revvity in the second quarter valued at $34,000. SJS Investment Consulting Inc. grew its position in Revvity by 5,210.0% during the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares during the period. Finally, Headlands Technologies LLC purchased a new position in shares of Revvity during the 2nd quarter valued at about $49,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Evercore reissued an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. TD Cowen reaffirmed a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Stifel Nicolaus decreased their price target on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. lowered their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, Revvity has an average rating of “Hold” and a consensus price target of $108.36.

Revvity Trading Down 1.3%

Shares of Revvity stock opened at $123.08 on Tuesday. The firm has a 50-day simple moving average of $111.90 and a two-hundred day simple moving average of $100.48. The company has a market cap of $13.73 billion, a P/E ratio of 58.61, a price-to-earnings-growth ratio of 2.27 and a beta of 1.07. Revvity Inc. has a fifty-two week low of $81.22 and a fifty-two week high of $124.97. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities analysts predict that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s payout ratio is 13.33%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.